Intech Investment Management LLC Buys 3,077 Shares of Balchem Co. (NASDAQ:BCPC)

Intech Investment Management LLC boosted its stake in Balchem Co. (NASDAQ:BCPC) by 55.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,611 shares of the basic materials company’s stock after acquiring an additional 3,077 shares during the period. Intech Investment Management LLC’s holdings in Balchem were worth $1,516,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Balchem by 1.5% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company’s stock valued at $604,000 after buying an additional 59 shares in the last quarter. Inspire Investing LLC boosted its holdings in shares of Balchem by 2.7% during the 3rd quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company’s stock valued at $413,000 after buying an additional 62 shares in the last quarter. Hsbc Holdings PLC boosted its holdings in shares of Balchem by 1.5% during the 2nd quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company’s stock valued at $757,000 after buying an additional 75 shares in the last quarter. Atomi Financial Group Inc. boosted its holdings in shares of Balchem by 6.1% during the 3rd quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company’s stock valued at $295,000 after buying an additional 96 shares in the last quarter. Finally, Xponance Inc. boosted its holdings in shares of Balchem by 5.2% during the 2nd quarter. Xponance Inc. now owns 2,046 shares of the basic materials company’s stock valued at $315,000 after buying an additional 102 shares in the last quarter. Institutional investors own 87.91% of the company’s stock.

Balchem Price Performance

BCPC opened at $182.69 on Tuesday. The stock has a 50-day moving average price of $173.84 and a 200-day moving average price of $166.71. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. The firm has a market cap of $5.94 billion, a PE ratio of 49.11, a P/E/G ratio of 5.45 and a beta of 0.65. Balchem Co. has a 1 year low of $120.87 and a 1 year high of $186.03.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on BCPC. StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th. HC Wainwright boosted their target price on shares of Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a report on Monday, November 4th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.